See Also: 9-beta-d-ribofuranosyladenine(medicine)
beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-acetylglucosaminyl transferase(medicine)
beta-1,3-galactosyl-0-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase(medicine)
UDP-GalNAc-beta-galactose beta 1,4-N-acetylgalactosaminyltransferase(medicine)
beta-1,4-mannosyl-glycoprotein beta-1,4-N-acetylglucosaminyltransferase(medicine)
beta-n-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase(medicine)
androst-5-ene-3 beta,17 beta-diol(medicine)
Beta-hydroxy-beta-methylglutaryl-CoA(medicine)
5 alpha-androstane-3 beta,17 beta-diol 6 alpha-hydroxylase(medicine)
5 alpha-androstane 3 beta,17 beta-diol 7 alpha-hydroxylase(medicine)

Tibetan (iou) and 9-beta-d-ribofuranosyladenine (medicine)


Tibetan (iou)



Tibetan noun & adjective. Also (earlier, now rare) Thibetan. E19.
[from TIBET + -AN.]
A. noun. A native or inhabitant of Tibet; the language of Tibet, a member of the Tibeto-Burman subfamily of Sino-Tibetan. E19.
B. adjective. Of or pertaining to Tibet, its inhabitants, or their language. E19.
Tibetan antelope = CHIRU. Tibetan cherry a white-flowered cherry tree, Prunus serrula, native to western China. Tibetan mastiff (an animal of) a breed of large black-and-tan dog with a thick coat and drop ears. Tibetan spaniel (an animal of) a breed of small white, brown, or black dog with a silky coat of medium length. Tibetan terrier (an animal of) a breed of grey, black, cream, or particoloured terrier with a thick shaggy coat.
Also Tibetian noun & adjective (now rare) M18.

9-beta-d-ribofuranosyladenine (medicine)


9-beta-d-ribofuranosyladenine -->
adenosine
<biochemistry> A ribonucleotide which consists of the nitrogenous base adenine linked to the sugar ribose.

<drug> A cardiac drug used in terminating PSVT involving reentry pathways that include the AV node or Wolff-Parkinson-White syndrome. For atrial flutter, atrial fibrillation, atrial or ventricular tachycardias, adenosine may produce transient AV block that may help identify the rhythm.

Pharmacologic action: Endogenous purine nucleoside that depresses AV node and sinus node activity. Brief duration of action (1-2 min).

Dose: Rapid 6 mg IV bolus over 1-3 sec. May repeat at 12 mg IV bolus within 1-2 min Patients taking theophylline may require larger doses. Use a smaller dose with cardiac transplant patients.

Potential complications: Common but transient - flushing, dyspnea, chest pain, bradycardia, and ventricular ectopy. Theophylline (and caffeine) blocks adenosine's effects. Dipyridamole potentiates adenosine's effects. Use Other agents to avoid these drug interactions.